Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01741350 · ClinicalTrials.gov registry record · NA
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
NCT01741350: Completed NA study, sponsored by University of Connecticut.
NCT01741350 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 304 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01741350, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
Study Summary
To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.
Primary Outcome
Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe.
Interventions
- BEHAVIORAL Community-friendly Health Recovery Program
- BEHAVIORAL Time-and-Attention-Matched Control Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT01741350 record still lists
NCT01741350 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Community-friendly Health Recovery Program is the first listed.
NCT01741350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01741350 about?
NCT01741350 is a clinical study titled "Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users". To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control con...
What is the current status of trial NCT01741350?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2006-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01741350?
The interventions under investigation include: Community-friendly Health Recovery Program (BEHAVIORAL), Time-and-Attention-Matched Control Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT01741350?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01741350's enrollment target sits among peer trials
304 327th of 2000 higher than 1,672 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia